dabigatran has been researched along with rhamnetin in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (rhamnetin) | Trials (rhamnetin) | Recent Studies (post-2010) (rhamnetin) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 80 | 0 | 49 |
| Protein | Taxonomy | dabigatran (IC50) | rhamnetin (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.7 | |
| ELAV-like protein 3 | Homo sapiens (human) | 1.2 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X | 1 |
1 review(s) available for dabigatran and rhamnetin
| Article | Year |
|---|---|
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis | 2022 |